Manager, Market Access & Implementation - Biosimilars - 563

About Civica:

Critical shortages of essential generic injectable drugs are an ongoing crisis in U.S. healthcare and have reached an all-time high. Over 300 essential medications are currently reported to be in shortage, according to industry and FDA reports.

Shortages put patients at risk and waste hospital resources.

Civica is a market-based nonprofit solution created in 2018 by health systems and philanthropies for the express purpose of preventing and mitigating drug shortages. Today, nearly 60 health systems have joined Civica, representing over 1,400 hospitals and approximately one-third of all U.S. hospital beds. Civica has also supplied the U.S. Department of Veteran’s Affairs, the U.S. Department of Defense and the U.S. Strategic National Stockpile with essential medicines. Civica currently supplies medicines to health system members in 49 states.

Civica’s mission has expanded beyond the hospital setting to reach consumers directly through CivicaScript, which is dedicated to making quality outpatient generic medicines affordable and available. CivicaScript works with trusted manufacturing partners to develop quality generic medicines and has forged partnerships with like-minded payors, pharmacy benefit managers and pharmacies to enable significant cost savings to be passed along to their customers.

Civica’s new 140,000 square foot state-of-the-art manufacturing facility in Virginia will soon produce a steady supply of more than three dozen sterile injectables, all drugs that are currently in or near shortage. The plant will also produce affordable biosimilar insulins, ensuring all Americans have access to lower cost, quality insulins, regardless of their insurance status.

The Civica Foundation is a 501(c)(3) organization that fosters philanthropic support for Civica’s work to manufacture and distribute affordable medications. The Foundation’s first commitment is to support Civica’s efforts to bring affordable insulin to all Americans. Leaders from nearly every corner of the diabetes ecosystem are partners in this initiative. 

Civica is leading a movement for patients, not profits. Because eliminating shortages and stabilizing high prices are in the best interest of patients.

Join us. Learn more at

Job Description:

The Manager, Market Access & Implementation plays a key role in driving access, utilization, and stakeholder engagement for the organization’s biosimilar portfolio. This individual will support market access strategy by working directly with health plans, PBMs, specialty and retail pharmacies, and provider groups to advance adoption and remove barriers to patient access.

The ideal candidate brings a deep understanding of the specialty product landscape, biosimilar dynamics, and stakeholder needs across the healthcare system. The position supports efforts for specialty biosimilars and our biosimilar insulin program. This is a highly collaborative role requiring cross-functional coordination and an ability to translate strategy into execution.

Essential Duties and Responsibilities:

• Stakeholder Engagement & Relationship Support
  • Support ongoing engagement with external partners including health plans, PBMs, and specialty/retail pharmacies to enhance biosimilar product access and implementation.
  • Assist in onboarding and operational readiness activities, including formulary alignment, benefit design planning, and pharmacy network readiness.
  • Assist in preparing payer- and provider-facing materials, including value decks, FAQs, and product overviews.
  • Participate in external meetings, track follow-ups, and ensure coordination across internal teams.
• Access Strategy & Execution
  • Contribute to the execution of payer access and pull-through strategies.
  • Monitor plan coverage trends, pharmacy channel activity, and provider utilization to identify opportunities or risks.
  • Collaborate with internal teams to address operational, distribution, or formulary access issues.
• Data, Insights & Reporting
  • Compile and analyze data from field teams, payer partners, and specialty pharmacy channels.
  • Track access milestones and prepare reports for internal stakeholders (e.g., coverage wins, pull-through progress).
  • Maintain stakeholder engagement trackers and support project management for access initiatives.
• Cross-Functional Coordination
  • Partner with Patient Access, Trade & Distribution, Medical Affairs, and Analytics teams to ensure aligned messaging and execution.
  • Support market access readiness for biosimilar product launches, including internal training and material development.
• Market Intelligence & Strategy: 
  • Monitor industry trends, competitor activities, and emerging vendor opportunities. Leverage insights to shape strategic direction and identify new avenues for growth and innovation.
• Performance Monitoring: 
  • Establish key performance indicators (KPIs) and benchmarks for partners and vendors. Continuously monitor relationships to ensure compliance, operational excellence, and mutual value creation.

Basic Qualifications and Capabilities:

• Required:
  • Bachelor’s degree in life sciences, business, health policy, or related field
  • 4–6 years of experience in pharmaceutical or biotech industry, including market access, account management, or trade/distribution
  • Understanding of specialty/retail pharmacy and biosimilar distribution models
  • Strong project management, communication, and stakeholder support skills
  • Proficiency with Excel, PowerPoint, and CRM or engagement tracking tools
• Preferred:
  • Experience with biosimilars or specialty therapeutic areas (e.g., oncology, endocrinology, immunology)
  • Experience with insulin or diabetes related medications.
  • Familiarity with payer reimbursement structures (Medicare Part B/D, commercial formularies, 340B)
  • Previous exposure to patient support programs or HUB models